JA PCM Project Leaflet (MS10)

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Lieve Dessing, Barthรฉlรฉmy Moreau de Lizoreux, Pauline De Wurstemberger
DOI: 10.5281/zenodo.18428288
Cited by: 0

Abstract

๐Œ๐ž๐ž๐ญ ๐ญ๐ก๐ž ๐„๐” ๐‰๐จ๐ข๐ง๐ญ ๐€๐œ๐ญ๐ข๐จ๐ง ๐จ๐ง ๐๐ž๐ซ๐ฌ๐จ๐ง๐š๐ฅ๐ข๐ฌ๐ž๐ ๐‚๐š๐ง๐œ๐ž๐ซ ๐Œ๐ž๐๐ข๐œ๐ข๐ง๐ž (๐๐‚๐Œ)Across Europe, cancer care is evolving - and JA PCM will help lead the way! ๐ŸŒ With ๐Ÿญ๐Ÿฐ๐Ÿฑ ๐ฉ๐š๐ซ๐ญ๐ง๐ž๐ซ๐ฌ ๐ฎ๐ง๐ข๐ญ๐ž๐ ๐ข๐ง ๐จ๐ง๐ž ๐„๐ฎ๐ซ๐จ๐ฉ๐ž๐š๐ง ๐‰๐จ๐ข๐ง๐ญ ๐€๐œ๐ญ๐ข๐จ๐ง, JA PCM is strengthening the Personalised Cancer Medicine network across Europe, ensuring personalised care will be widely accessible and reaches all patients in need.๐Ÿ”Ž Curious to learn more about our ambitious European Joint Action? Take a look in the leaflet!

Fields of Study & Subjects

Science Research and Medicine Cancer Genomics and Diagnostics Advances in Oncology and Radiotherapy

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
31 January 2026
Language
EN